Penumbra (PEN) Net Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.00 |
| Dec 31, 2025 | 847.00 |
| Sep 30, 2025 | 1,767.00 |
| Jun 30, 2025 | 2,406.00 |
| Mar 31, 2025 | 1,087.00 |
| Dec 31, 2024 | 408.00 |
| Sep 30, 2024 | 163.00 |
| Jun 30, 2024 | -3,214.00 |
| Mar 31, 2024 | -424.00 |
| Dec 31, 2023 | 1,384.00 |
| Sep 30, 2023 | 2,251.00 |
| Jun 30, 2023 | -495.00 |
| Mar 31, 2023 | -180.00 |
| Dec 31, 2022 | -770.00 |
| Sep 30, 2022 | -135.00 |
| Jun 30, 2022 | 16.00 |
| Mar 31, 2022 | 428.00 |
| Dec 31, 2021 | -880.00 |
| Sep 30, 2021 | -1,058.00 |
| Jun 30, 2021 | -12.00 |
| Mar 31, 2021 | 523.00 |
| Dec 31, 2020 | 80.00 |
| Sep 30, 2020 | -530.00 |
| Jun 30, 2020 | -941.00 |
| Mar 31, 2020 | -5.00 |
| Dec 31, 2019 | 637.00 |
| Sep 30, 2019 | 1,184.00 |
| Jun 30, 2019 | 1,178.00 |
| Mar 31, 2019 | 712.00 |